Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Digital Health in Neurology Market Size, Share, Trends, and Forecast, 2026-2033 | AI, Telehealth, and Remote Monitoring Propel Market to USD 246.9 Billion at 22.6% CAGR

globenewswire.com

Digital Health in Neurology Market Size, Share, Trends, and Forecast, 2026-2033 | AI, Telehealth, and Remote Monitoring Propel Market to USD 246.9 Billion at 22.6% CAGR Dublin, Nov. 10, 2026 (GLOBE NEWSWIRE) -- "Digital Health In Neurology Market Size, Share & Trends Analysis Report 2026-2033" has been added to ResearchAndMarkets.com's offering.

Digital Health in Neurology Market Projected to Reach USD 246.9 Billion by 2033

The global digital health in neurology market was valued at USD 48.5 billion in 2025 and is projected to increase from USD 59.4 billion in 2026 to USD 246.9 billion by 2033. According to the report, the market is expected to expand at a compound annual growth rate of 22.6% from 2026 to 2033. North America led the global market in 2025, accounting for 40.0% of total revenue.

Market growth is being supported by rising smartphone penetration, stronger healthcare IT infrastructure, improved internet connectivity, increasing healthcare expenditure, and greater accessibility of virtual care. The growing prevalence of chronic and neurological conditions is also increasing demand for remote patient monitoring, telemedicine, digital therapeutics, wearable technologies, and connected care platforms.

The pandemic accelerated the adoption of digital health technologies across disease management, technology development, and frontline care delivery. Healthcare systems worldwide expanded their use of telehealth, telemedicine, and remote monitoring platforms to improve communication between physicians and patients. This shift established digital care as an increasingly important component of neurological care and long-term disease management.

Government investment in healthcare digitalization is creating additional opportunities for the digital health in neurology market. In January 2024, the European Commission awarded an EU-funded collaborative research infrastructure grant of approximately USD 41 million to EBRAINS. The funding, which extends through 2026, supports the development of tools and services such as digital twin approaches for brain medicine, neuroscience, and brain-inspired technologies.

IoT adoption is also strengthening the role of connected healthcare platforms. Advanced wearable devices, mobile connectivity, integrated analytics, and data management systems support patient monitoring, chronic condition management, medication optimization, inventory oversight, and medical equipment availability. These capabilities are helping providers improve clinical workflows while enabling more continuous and personalized neurological care.

Investment in AI-powered neural interfaces further highlights the pace of innovation. In April 2025, Phantom Neuro completed a USD 19 million Series A funding round led by Ottobock. The financing is intended to accelerate regulatory activities, clinical validation, product development, and commercialization of Phantom X, a muscle-machine interface designed to provide intuitive control of prosthetic limbs and robotic devices.

Smartphone-based health applications are another important market driver, particularly for sleep tracking, stress management, remote monitoring, and neurological well-being. In July 2025, Apollo Neuroscience launched Version 4.0 of its mobile application. The update introduced a redesigned user interface, personalized content recommendations, improved SmartVibes integration, and enhanced wearable connectivity, supporting a more integrated digital therapeutic experience.

The growing global burden of neurological disorders continues to increase the need for scalable digital care solutions. World Health Organization estimates indicate that approximately 55 million people worldwide are living with dementia. Its 2025 global neurology findings also indicate that neurological conditions affect more than 40% of the global population, representing over 3 billion people. These conditions remain a leading cause of ill health and disability, encouraging companies and research institutions to invest in clinical trials and digital neurology technologies.

Market Segmentation

The report evaluates revenue growth and industry opportunities at global, regional, and country levels from 2021 to 2033. Market analysis is organized across the following segments:

Key Benefits of the Report

As virtual care, connected devices, AI-powered platforms, and remote monitoring become more deeply integrated into neurological care, the digital health in neurology market is positioned for sustained expansion through 2033.

Key Topics Covered:

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope

1.1.1. Component

1.1.2. End Use

1.1.3. Regional scope

1.1.4. Estimates and forecast timeline.

1.2. Research Methodology

1.3. Information Procurement

1.3.1. Purchased database.

1.3.2. The internal database

1.3.3. Secondary sources

1.3.4. Primary research

1.3.5. Details of primary research

1.4. Information or Data Analysis

1.4.1. Data analysis models

1.5. Market Formulation & Validation

1.6. Model Details

1.6.1. Commodity flow analysis (Model 1)

1.6.2. Approach 1: Commodity flow approach

1.6.3. Volume price analysis (Model 2)

1.6.4. Approach 2: Volume price analysis

1.7. List of Secondary Sources

1.8. List of Primary Sources

1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook

2.2. Segment Outlook

2.2.1. Component outlook

2.2.2. End Use outlook

2.2.3. Regional outlook

2.3. Competitive Insights

Chapter 3. Digital Health In Neurology Market Variables, Trends & Scope

3.1. Market Lineage Outlook

3.1.1. Parent market outlook

3.1.2. Related/ancillary market outlook

3.2. Market Dynamics

3.2.1. Market driver analysis

3.2.1.1. Growing adoption of digital technology in neurology care

3.2.1.2. Increasing use of artificial intelligence (AI), internet of things (IoT), and big data

3.2.1.3. Growing adoption of mobile health applications and technologies

3.2.1.4. Increasing burden of neurological disorders

3.2.2. Market restraint analysis

3.2.2.1. Privacy and security concerns

3.2.2.2. Lack of healthcare infrastructure

3.3. Digital Health In Neurology Market Analysis Tools

3.3.1. Industry Analysis - Porter's

3.3.1.1. Supplier power

3.3.1.2. Buyer power

3.3.1.3. Substitution threat

3.3.1.4. Threat of new entrant

3.3.1.5. Competitive rivalry

3.3.2. PESTEL Analysis

3.3.2.1. Political landscape

3.3.2.2. Technological landscape

3.3.2.3. Economic landscape

Chapter 4. Digital Health In Neurology Market: Component Estimates & Trend Analysis

4.1. Definition and Scope

4.2. Component Market Share, 2025 & 2033

4.3. Segment Dashboard

4.4. Global Digital Health In Neurology Market by Component Outlook

4.5. Software

4.5.1. Market estimates and forecast 2021 to 2033 (USD Million)

4.6. Hardware

4.6.1. Market estimates and forecast 2021 to 2033 (USD Million)

4.7. Services

4.7.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 5. Digital Health In Neurology Market: End Use Estimates & Trend Analysis

5.1. Definition and Scope

5.2. End Use Market Share, 2025 & 2033

5.3. Segment Dashboard

5.4. Global Digital Health In Neurology Market by End Use Outlook

5.5. Patients

5.5.1. Market estimates and forecast 2021 to 2033 (USD Million)

5.6. Providers

5.6.1. Market estimates and forecast 2021 to 2033 (USD Million)

5.7. Payers

5.7.1. Market estimates and forecast 2021 to 2033 (USD Million)

5.8. Others

5.8.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 6. Digital Health In Neurology Market: Regional Estimates & Trend Analysis, Component, End Use

6.1. Regional Market Share Analysis, 2025 & 2033

6.2. Regional Market Dashboard

6.3. Global Regional Market Snapshot

6.4. SWOT Analysis, Region

6.5. North America

6.5.1. U.S.

6.5.2. Canada

6.6. Europe

6.6.1. UK

6.6.2. Germany

6.6.3. France

6.6.4. Italy

6.6.5. Spain

6.6.6. Norway

6.6.7. Sweden

6.6.8. Denmark

6.7. Asia Pacific

6.7.1. Japan

6.7.2. China

6.7.3. India

6.7.4. Australia

6.7.5. South Korea

6.7.6. Singapore

6.8. Latin America

6.8.1. Brazil

6.8.2. Mexico

6.8.3. Argentina

6.9. MEA

6.9.1. South Africa

6.9.2. Saudi Arabia

6.9.3. UAE

6.9.4. Kuwait

6.10. Country Analysis Coverage

6.10.1. Key country dynamics

6.10.2. Regulatory framework/ reimbursement structure

6.10.3. Competitive scenario

6.10.4. Country market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

7.1. Recent Developments & Impact Analysis, Key Market Participants

7.2. Company/Competition Categorization

7.2.1. Innovators

7.3. Vendor Landscape

7.3.1. Key company market share analysis, 2025

7.3.2. Neofect

7.3.3. Teladoc

7.3.4. Proteus Digital Health

7.3.5. Akili Labs

7.3.6. AppliedVR

7.3.7. Aural Analytics

7.3.8. BehaVR

7.3.9. BetterHelp

7.3.10. Big Health

7.3.11. Omada Health

7.3.12. Blackrock Neurotech

7.3.13. AdvancedMD

7.4. Company Profile Coverage

7.4.1. Company overview

7.4.2. Financial performance

7.4.3. Product benchmarking

7.4.4. Strategic initiatives

List of Tables [62]

List of Figures [93]

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/dlcxpu

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.